Results 121 to 130 of about 50,022 (297)

Predicting Response to Pro‐Cognitive Interventions in Mood Disorders: A Systematic Review by the International Society for Bipolar Disorders Targeting Cognition Task Force

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Introduction Major depressive disorder (MDD) and bipolar disorder (BD) are often associated with persistent cognitive deficits that impair psychosocial functioning. While pro‐cognitive interventions show promise, trial findings are inconsistent, potentially due to baseline factors influencing treatment response.
Dimosthenis Tsapekos, Michail Kalfas, Johanna M. Schandorff, Caterina del Mar Bonnin, Christopher R. Bowie, Vicent Balanzá‐Martínez, Katherine E. Burdick, Andre F. Carvalho, Annemieke Dols, Katie Douglas, Peter Gallagher, Gregor Hasler, Lars V. Kessing, Hanne L. Kjærstad, Beny Lafer, Kathryn E. Lewandowski, Carlos López‐Jaramillo, Anabel Martinez‐Aran, Roger S. McIntyre, Richard J. Porter, Scot E. Purdon, Ayal Schaffer, Paul R. A. Stokes, Tomiki Sumiyoshi, Ivan J. Torres, Tamsyn E. Van Rheenen, Lakshmi N. Yatham, Jeff Zarp, Allan H. Young, Eduard Vieta, Kamilla W. Miskowiak   +30 more
wiley   +1 more source

Art in the abyss: creativity and the schizophrenic mind. [PDF]

Front Psychiatry
T S S, Raj G, Kiso K, Kharmih D, Yepthomi K, Kumar Gupta S, Thou G, Ashok S, T L A, Maria Benno A.   +9 more
europepmc   +1 more source

The Effectiveness of Positive Psychology Based Intervention on Anhedonia, and Internalized Stigma among Schizophrenic Patients

Hanaa Abd el hameed Radwan, Nehal Sobhy Emaraa, Elham Ramzy Elfiky   +2 more
openalex   +1 more source

Use of the booklet category test to assess abstract concept formation in schizophrenic disorders [PDF]

, 2012
Boyle, Gregory J., Steindl, Stanley R.
core  

Unpacking the link between substance use disorders and 30‐day unplanned readmission

Addiction, EarlyView.
Abstract Background and Aims Given the more than twofold increase in the prevalence of substance use disorders in the United States in the past decade, more hospital inpatients can be expected to carry substance use disorder diagnoses, necessitating evaluation of potential links to 30‐day unplanned readmissions, a marker of quality of care.
Allison D. Rosen, Sae Takada, Catherine Juillard, Yulsi L. Fernandez Montero, Amy M. Richards, Serge Ngekeng, Steven J. Shoptaw, Michelle A. Bholat   +7 more
wiley   +1 more source

Editorial: Phenomenological psychopathology: who, what and how? An analysis of key figures, advancements and challenges. [PDF]

Front Psychol
Ferrarello S, Brencio F, Bizzari V, Englander M.   +3 more
europepmc   +1 more source

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial

Addiction, EarlyView.
Abstract Background and Aims Psilocybin has emerged as a potential treatment for alcohol use disorder (AUD), but early efficacy data are inconsistent. Depression following alcohol detoxification significantly increases the risk of relapse. This pilot study aimed to evaluate the feasibility, acceptability, and preliminary efficacy of psilocybin‐assisted
Amandine Luquiens, Dahbia Belahda, Carine Graux, Noe Igounenc, Chris Serrand, Paul Rochefort, Thibault Mura, Felix Sergent   +7 more
wiley   +1 more source

The Correlation of Blood Immune Cells with the Pathogenesis of Schizophrenia: A Meta-Analysis. [PDF]

Iran J Public Health
Xue F, Li Z, Yan L, Yu Q, Zhang Y.
europepmc   +1 more source

Externalizing as a common genetic influence for a broad spectrum of substance use and behavioral conditions: A developmental perspective from the Avon Longitudinal Study of Parents and Children

Addiction, EarlyView.
Abstract Background and aims Recent large studies have established the genetic basis of several conceptually linked phenotypes of externalizing. Polygenic risk scores (PRSs) for these constructs are associated with a range of substance use and mental disorder phenotypes but have not been examined with both pharmacological and non‐pharmacological ...
Wei Q. Deng, Kyla Belisario, Amanda Doggett, Marie Pigeyre, Guillaume Pare, Marcus R. Munafò, James MacKillop   +6 more
wiley   +1 more source

Comparative effectiveness of urine drug testing schedules alongside opioid agonist treatment: Emulation of a population‐based target trial in British Columbia, Canada

Addiction, EarlyView.
Abstract Background and aim Urine drug testing is often utilized alongside opioid agonist treatment to assess client progress by validating self‐reported substance use, monitoring for diversion and supporting clinical decisions for take‐home dosing. However, there is a paucity of evidence to support the practice of urine drug testing.
Megan Kurz, Brenda Carolina Guerra‐Alejos, Jeong Eun Min, Shaun R. Seaman, Micah Piske, Paxton Bach, Julie Bruneau, Sander Greenland, Paul Gustafson, Kyle Kampman, Mohammad Ehsanul Karim, P. Todd Korthuis, Robert W. Platt, Uwe Siebert, M. Eugenia Socías, Evan Wood, Bohdan Nosyk   +16 more
wiley   +1 more source